FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885664088> ?p ?o ?g. }

• W2885664088 abstract "Multiple myeloma is the second most common hematological malignancy with an estimated 30,000 new diagnoses in 2017. Myeloma cells retain numerous characteristics of normal plasma cells including reliance on survival signals in the bone marrow for long term viability. However, they have gained the capacity to proliferate, causing harmful bone lesions in patients, and in advanced stages become extramedullary. Therefore, we are investigating molecular mechanisms of myeloma cells that allow them to survive independently of the bone marrow microenvironment. We have identified syntenin as a protein involved in myeloma cell survival and a potential therapeutic target. Syntenin has been reported to bind to and regulate levels of the plasma cell marker, CD138. We used the CoMMpass dataset, a longitudinal study of myeloma patients following their transcriptomic expression throughout treatment, and discovered that patients expressing in the top quartile for syntenin trend toward lower overall survival, progression-free survival, and shorter response duration than those in the bottom quartile. To determine whether it is involved in myeloma cell survival, we used short hairpin RNA to knock down syntenin (shsyn) in RPMI 8226 and MM1.s myeloma cell lines and determined cell death using Annexin-V staining four days following lentiviral infection. We observed increased death in syntenin-silenced cells compared to our empty vector control in both RPMI 8226 (control=57.83% viable, shsyn=29.47% viable, p=0.04) and MM1.s cell lines (control=91.43% viable, shsyn=70.1% viable, p=0.04) suggesting that syntenin is important for myeloma cell survival. Syntenin is a PDZ-domain containing protein that has been shown to regulate expression of several transmembrane proteins. We, therefore, wanted to look at correlation of syntenin expression with CD138 and CD86, two PDZ-binding domain containing proteins expressed on the surface of myeloma cells. Using the CoMMpass dataset, we found patients with high expression of syntenin had increased expression of CD86 while syntenin-low patients had decreased CD86 expression. This correlation does not exist with CD138 as syntenin-low patients express higher levels of CD138. The correlation with CD86 but not CD138 suggests a previously undescribed role for syntenin in myeloma cells. Our lab has shown that expression of CD86 is necessary for myeloma cell survival, and signals to confer drug resistance. When we silenced syntenin, we observed decreased CD86 expression. Moreover, knockdown of CD86 showed increased expression of syntenin. Taken together, these data suggest that syntenin may regulate CD86 expression on the cell surface. We now show a novel role for syntenin in myeloma cell viability and as a potential regulator of CD86 expression. Syntenin has not previously been explored in multiple myeloma and determining its molecular function is warranted as it may be an effective target for therapeutic treatment of the disease. Citation Format: Tyler Moser-Katz, Catherine M. Gavile, Benjamin G. Barwick, Sagar Lonial, Lawrence H. Boise. Syntenin regulates multiple myeloma cell survival [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 319." @default.
• W2885664088 created "2018-08-22" @default.
• W2885664088 creator A5010305352 @default.
• W2885664088 creator A5023276777 @default.
• W2885664088 creator A5023992896 @default.
• W2885664088 creator A5033852460 @default.
• W2885664088 creator A5046430988 @default.
• W2885664088 date "2018-07-01" @default.
• W2885664088 modified "2023-09-25" @default.
• W2885664088 title "Abstract 319: Syntenin regulates multiple myeloma cell survival" @default.
• W2885664088 doi "https://doi.org/10.1158/1538-7445.am2018-319" @default.
• W2885664088 hasPublicationYear "2018" @default.
• W2885664088 type Work @default.
• W2885664088 sameAs 2885664088 @default.
• W2885664088 citedByCount "0" @default.
• W2885664088 crossrefType "proceedings-article" @default.
• W2885664088 hasAuthorship W2885664088A5010305352 @default.
• W2885664088 hasAuthorship W2885664088A5023276777 @default.
• W2885664088 hasAuthorship W2885664088A5023992896 @default.
• W2885664088 hasAuthorship W2885664088A5033852460 @default.
• W2885664088 hasAuthorship W2885664088A5046430988 @default.
• W2885664088 hasConcept C126322002 @default.
• W2885664088 hasConcept C203014093 @default.
• W2885664088 hasConcept C2776364478 @default.
• W2885664088 hasConcept C2776396001 @default.
• W2885664088 hasConcept C2779399171 @default.
• W2885664088 hasConcept C2780007613 @default.
• W2885664088 hasConcept C502942594 @default.
• W2885664088 hasConcept C71924100 @default.
• W2885664088 hasConcept C86803240 @default.
• W2885664088 hasConceptScore W2885664088C126322002 @default.
• W2885664088 hasConceptScore W2885664088C203014093 @default.
• W2885664088 hasConceptScore W2885664088C2776364478 @default.
• W2885664088 hasConceptScore W2885664088C2776396001 @default.
• W2885664088 hasConceptScore W2885664088C2779399171 @default.
• W2885664088 hasConceptScore W2885664088C2780007613 @default.
• W2885664088 hasConceptScore W2885664088C502942594 @default.
• W2885664088 hasConceptScore W2885664088C71924100 @default.
• W2885664088 hasConceptScore W2885664088C86803240 @default.
• W2885664088 hasLocation W28856640881 @default.
• W2885664088 hasOpenAccess W2885664088 @default.
• W2885664088 hasPrimaryLocation W28856640881 @default.
• W2885664088 hasRelatedWork W1978349704 @default.
• W2885664088 hasRelatedWork W2005843898 @default.
• W2885664088 hasRelatedWork W2038934968 @default.
• W2885664088 hasRelatedWork W2409408562 @default.
• W2885664088 hasRelatedWork W2791870662 @default.
• W2885664088 hasRelatedWork W2794101941 @default.
• W2885664088 hasRelatedWork W2802828592 @default.
• W2885664088 hasRelatedWork W2893011256 @default.
• W2885664088 hasRelatedWork W3110108976 @default.
• W2885664088 hasRelatedWork W4283034076 @default.
• W2885664088 isParatext "false" @default.
• W2885664088 isRetracted "false" @default.
• W2885664088 magId "2885664088" @default.
• W2885664088 workType "article" @default.